Alleviant Medical, Inc. is a medical device company developing a minimally invasive, implant-free interatrial shunt device under clinical investigation for the treatment of chronic heart failure. The Alleviant System was granted U.S. FDA Breakthrough Device Designation in 2021.The interventional procedure is intended to decompress the left atrium for heart failure patients without requiring a permanent cardiac implant or open surgery.